Icrucumab Antibody
Icrucumab (IMC-18F1) is a humanized IgG1 monoclonal antibody that inhibits vascular endothelial growth factor receptor-1 (VEGFR-1) . It has demonstrated antitumor activity and has been investigated in preclinical models and clinical trials for metastatic colorectal cancer.
Product Specifications
Product Name Alternative
VEGFR, IMC-18F1, LY 3012212
Target
VEGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
5.97 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
G0586 96 Tests
PRB (Retinoblastoma Tumor Suppressor Protein) Human ELISA Kit
Sign In for Pricing
View Details 